Wongkonkitsin Narongchai, Phugkhem Ake, Jenwitheesuk Kriangsak, Saeseow O-Tur, Bhudhisawasdi Vajarabhongsa
General Surgery 3 Unit, Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
J Med Assoc Thai. 2006 Nov;89(11):1890-5.
To compare the survival probability of unresectable hilar cholangiocarcinoma patients who have been managed by palliative surgical bypass versus percutaneous transhepatic biliary drainage (PTBD).
A historical (retrospective) cohort study was performed by retrospective and prospective data collection. From January 1, 2000 to December 31, 2002, all unresectable hilar cholangiocarcinoma patients who received only one type of palliative surgical bypass or PTBD in Srinagarind Hospital, Khon Kaen University were included in the present study. The patients were followed until December 31, 2004. Survival analysis was completed for all of the patients. STATISTIC ANALYSIS: Survival analysis was analyzed with the Kaplan-Meier method, Cox regression analysis, and Log-rank test. A p-value of less than 0.05 was considered significant.
During the study period, 83 patients were included. Palliative surgical bypass was performed in 42 patients and PTBD was performed in 41 patients. Demographic data, peri-operative complication rate, and late complication rate were comparable. The median survival time of the palliative surgical bypass group was 160 days,(95% CI: 85.33, 234.67) and 82 days (95% CI: 29.76, 134.24)for PTBD group. Comparing survival experience by Log-rank test gave statistical significant diference (p = 0.0276). Hazard ratio was 0.599 (p = 0.03)
Survival rate of the palliative surgical bypass group was higher than the PTBD group. The survival rate of both groups was comparable to previous reports.
比较接受姑息性手术旁路治疗与经皮肝穿胆道引流术(PTBD)的不可切除肝门部胆管癌患者的生存概率。
通过回顾性和前瞻性数据收集进行一项历史性(回顾性)队列研究。2000年1月1日至2002年12月31日期间,孔敬大学诗里拉医院所有仅接受一种姑息性手术旁路治疗或PTBD的不可切除肝门部胆管癌患者纳入本研究。对患者进行随访直至2004年12月31日。对所有患者完成生存分析。
采用Kaplan-Meier法、Cox回归分析和对数秩检验进行生存分析。p值小于0.05被认为具有显著性。
研究期间,纳入83例患者。42例患者接受了姑息性手术旁路治疗,41例患者接受了PTBD。人口统计学数据、围手术期并发症发生率和晚期并发症发生率具有可比性。姑息性手术旁路治疗组的中位生存时间为160天(95%可信区间:85.33,234.67),PTBD组为82天(95%可信区间:29.76,134.24)。通过对数秩检验比较生存经验有统计学显著差异(p = 0.0276)。风险比为0.599(p = 0.03)。
姑息性手术旁路治疗组的生存率高于PTBD组。两组的生存率与先前报告相当。